CorMedix (CRMD) announced it will be added to the Nasdaq Biotechnology Index (NBI). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks